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Abstract 
Objective 
Prolonged exposure is characterized by reported dropout rates ranging from 25% to 
40%. This premature attrition is also observed in other evidence-based treatments for 
posttraumatic stress disorder. While home-based telehealth delivery of prolonged 
exposure resolves logistical barriers to care such as travel time and cost, dropout 
appears unaffected. A previous study on dropouts from prolonged exposure delivered 
via telehealth found that Veterans, particularly those receiving care via telehealth, 
reported problems with in vivo exposure and that having a peer to offer support during 
in vivo exposure assignments might have prevented their attrition from treatment. 
Methods 
The present pilot study treatment was designed in a manner consistent with the 
aforementioned Veteran suggestions, specifically to involve peers offering verbal 
support and encouragement during in vivo exposure homework. Such a treatment 
modification might be particularly useful for those receiving care via telehealth, given 
increased difficulties with exposure reported when this treatment delivery modality is 
used. It was hypothesized that dropouts would agree to reengage in treatment with a 
peer and would subsequently evince improvement in posttraumatic stress disorder and 
depression scores as a result of this treatment reengagement. 
Results 
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Of 82 dropouts from prolonged exposure, 29 reentered treatment when offered peer 
support during exposure (12 in telehealth and 17 in person). 
Conclusion 
Treatment reentry was effective insofar as indices of both posttraumatic stress disorder 
and depression were significantly reduced in both telehealth and in person groups, 
indicating that using peers in this way may be an effective means by which to return 
Veterans to care, and ultimately reduce symptomatology. 
Keywords telehealth, posttraumatic stress disorder, Veterans, depression, dropout 
Introduction 
Posttraumatic stress disorder (PTSD) is a debilitating condition characterized by high 
comorbidity with other mental and physical health disorders1 and affects approximately 
15%–20% of Vietnam Veterans,2–4 10%–15% of Persian Gulf War Veterans,5 and up 
to 23% of Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) 
Veterans.6 Fortunately, effective treatments for PTSD including combat-related PTSD 
exist, such as prolonged exposure (PE) and cognitive processing therapy (CPT).7–
10 Recommended pharmacological interventions, despite their relative ease of 
implementation, do not produce the same degree of treatment improvement as the 
exposure-based psychotherapies.10,11 However, evidence-based psychotherapies 
such as PE and CPT are plagued by relatively high rates of dropout, with approximately 
30%–40% of patients terminating treatment prematurely12–19 and continuing to 
experience problems that have significant impact on themselves, their families, and 
the systems (e.g., Department of Veterans Affairs (VA)) and communities within which 
they live.20,21 
Consistent with aforementioned treatment guidelines, and in keeping with increased 
awareness of psychological suffering in Vietnam, Persian Gulf, and OEF/OIF service 
era Veterans,18,22,23VA24 recommended that all Veterans in their care with PTSD have 
access to these evidence-based treatments. To meet this need, all psychotherapy 
providers in VA services who primarily served Veterans with PTSD were trained in 
either PE or CPT (or both) through formal workshops followed by a six-month 
supervision consultation program.25–28 Moreover, the Department of Defense (DoD) 
and VA implemented postdeployment screening for mental health problems at all 
primary care visits.29 As a result of this tremendous and coordinated investment, 
Veterans and active duty personnel are more likely than ever to be identified and 
referred to effective PTSD treatment. 
Given this massive effort and associated expense, it is rather disconcerting that of 
those who attend the first session, between 25% and 40% eventually dropped out of 
PE or CPT prior to completion.13 Thus, because PTSD symptoms persist over time in 
the absence of treatment, and in light of the tremendous resources directed toward 
training providers in evidence-based treatment for PTSD,22 research to address the 
problem of dropout is essential. However, dropouts virtually always receive less 
research attention than treatment completers by the very nature of the fact that they 
frequently also drop out of the study within which the treatment is offered. Additionally, 
even when dropouts in treatment outcome research do agree to continue to participate 
in follow-up assessment, their numbers are relatively small because the original trials 
from which they dropped were statistically powered with respect to intent-to-treat or 
completer analyses, not dropout analyses. 
Efforts to retain patients in or return dropouts to evidence-based treatment for PTSD 
have included leveraging technology to resolve barriers to care, such as delivering 
treatment through telehealth, or even home-based telehealth. Specifically, delivering 
PE via telehealth was presented as a strategy to reduce dropout insofar as telehealth 
addresses logistical factors such as travel time, distance, and related costs, while 
reducing disparities in access to care for those in remote/rural areas.30–32 However, 
despite the apparent logistical advantages of home-based telehealth-delivered 
treatment for PTSD, rates of dropout remained unchanged at about 26%.15Moreover, 
those in the telehealth condition reported that completing exposure-based PTSD 
treatment was more difficult. That is, while evincing similar levels of improvement to 
standard in-person care, participants receiving exposure-based psychotherapy for 
PTSD reported increased anxiety and hypervigilance, particularly during in vivo 
exposure homework completion.15,33 
Clearly, the problem of dropout from evidence-based psychotherapy for PTSD will not 
be solved by telehealth alone. Fortunately, prior research indicates social support may 
lower attrition from psychotherapy,34–36 and formalized peer social support programs, 
often referred to as “peer navigation” services, enhance treatment engagement by 
creating a means by which peers who have completed treatment assist those currently 
in treatment.37,38 Along these lines, we interviewed Veterans who had dropped out from 
PE in an attempt to identify factors that might be useful in preventing or reversing 
dropout.15 One consistent report from these Veterans was that in vivo exposure 
homework, a key treatment component of PE in which patients are required to 
approach previously avoided environmental stimuli because they remind the patient of 
the traumatic event and elicit significant anxiety, was particularly difficult to complete. 
Moreover, these patients reported that they might not have dropped out, and might 
consider returning to treatment, if they had the support of a Veteran peer who had 
successfully completed the treatment during in vivo exposure homework sessions. 
Thus, we hypothesized that peer social support, brought to bear directly during in vivo 
exposure homework, might be particularly useful when treating PTSD with PE 
delivered via home-based telehealth, potentially addressing, in part, the problem of 
dropout from PE while attending to aforementioned patient report of increased anxiety 
associated with PE treatment components in telehealth patients. 
Using peers to enhance treatment success is by no means novel, and in fact, the VA 
has initiated a peer support program throughout its medical centers.39 However, in 
these programs, peers are typically used to enhance treatment engagement, facilitate 
treatment initiation, and offer extra-treatment support. Using peers directly to assist in 
core PTSD treatment components such as in vivo exposure homework taking place 
outside VA facilities has not been reported and is actually specifically prohibited by 
most peer support program guidelines. Nonetheless, Veterans in the aforementioned 
dropout study15 indicated that such peer support was consistent with the “buddy 
system” training they had received in the military and that the presence of a peer 
directly during in vivo exposure homework would have been sufficiently compelling to 
prevent their premature treatment termination. 
In response to this feedback, we designed and subsequently assessed the feasibility 
of using peer support during in vivo exposure homework and found that (1) offering 
peer support directly during a limited number of in vivo exposure homework sessions 
can reengage dropouts from PE back into treatment, (2) Veterans who have 
successfully completed treatment are willing to serve as peers and offer support during 
in vivo exposure homework to other Veterans with PTSD who are at risk of, or who 
have already dropped out of treatment, and (3) satisfaction with such a program on the 
part of the peer and on the part of the patient is high.40 The present study compliments 
aforementioned feasibility findings with preliminary evidence regarding symptom 
improvement among PE dropouts who returned to treatment with a peer offering verbal 
support directly during a limited number of in vivo homework assignments. 
Methods 
Overview 
Participants who had dropped out from treatment offered through two RCTs comparing 
in person versus home-based telehealth-delivered PE were contacted by telephone 
and offered the opportunity to return to treatment, this time with the assistance of a 
peer who would meet them at in vivo exposure homework sites in the community and 
offer verbal support during in vivo exposure homework. This was described to 
participants as being roughly analogous to having a weight-lifting “workout buddy” 
during in vivo exposure exercises, which were conceptualized as “a mission they would 
face together, as they had been trained to do.” They also reinitiated PE with their 
former therapists in the same treatment delivery modality (i.e., in person or home-
based telehealth), and this therapist coordinated communication with the peer and 
patient. Peers were Veterans who successfully completed PE therapy and no longer 
meet PTSD diagnostic criteria (see Hernandez-Tejada et al.40 for extensive discussion 
of this peer program and its feasibility). 
Procedures 
Once a patient agreed to return to treatment with a peer who offered support during in 
vivo exposure, they attended a session with their therapist wherein the exposure 
hierarchy was reviewed and a telephone call with the peer was held (i.e., on 
speakerphone so that both patient and therapist could communicate with peer). 
Patient, peer, and therapist jointly identified one or two in vivo exposure items, the time 
and place homework would take place, and patient and peer agreed to meet at the 
exposure site. Both patients and peers were instructed to telephone the therapist 
following the first homework meeting to discuss how the process went and to assure 
that the next in vivo session with the peer was scheduled. If both parties were willing, 
the program persisted with three to four meetings per week for 3–4 weeks of the 12-
week PE protocol sessions. 
Peers were trained to offer verbal support during exposure homework to help patients 
complete assignments and stay in the anxiety-provoking situation for as long as they 
could tolerate. Peers were allowed to share their own recovery stories during in vivo 
homework if similarities were observed between patient and peer experiences of 
avoidance. Geographic proximity was the criteria used to pair peers with patients. 
Peers and patients were not permitted to drive together in their own vehicles and to go 
to each other’s residences, shooting ranges, or any other place evaluated as 
dangerous. 
Participants 
PE dropouts contacted for this study were 82 Veterans (75 male and 7 female) who 
had prematurely terminated evidence-based treatment for PTSD and continued to 
meet PTSD diagnostic criteria at the point of dropout. Participants were male and 
female Veterans of Vietnam, Persian Gulf, and OIF/OEF conflicts, aged 21 and older. 
Patients with psychosis or dementia were excluded from participation, but other forms 
of psychopathology (e.g., depression) were not excluded. Approximately 35%–40% of 
participants resided in rural areas. Of the original 82 dropouts from PE, 43 (52.4%) 
indicated their intention to return back to treatment with peer support when such an 
offer was made. Of these 43, 29 of the 82 (35.4%) reengaged in treatment. The 
remaining 14 of the 82 (17.1%) continued to indicate an interest in returning to 
treatment but did not do so for reasons including relocation (5 of the 14) and lack of 
time off from work or family responsibilities. Demographic characteristics of the 29 who 
reengaged in treatment are given in Table 1. A majority was black, male, and served 
in the OIF/OEF conflicts. Most were also employed and lived relatively close to the VA 
hospital (≤30 miles). 
Table 1. Demographics characteristics of the 29 participants returning to treatment. 
 
VA: Veterans Affairs. 
Measures 
Demographic variables were collected at baseline assessment in the parent studies, 
and included age, race, ethnicity, gender, marital status, educational level, income, 
service connection/disability rating, branch of service, and war theater served. 
PTSD Checklist-Military (PCL-M) 
The PCL-M41 is a 17-item self-report measure of PTSD symptoms based on DSM-IV 
criteria. The PCL-M uses a 5-point Likert scale response format ranging from not at all 
(1) to extremely (5). Total scores on the PCL-M range from 17 to 85. A change of 10–
20 points from the baseline score is considered clinically meaningful.42 The instrument 
is highly correlated with the clinician administered PTSD scale (r = .93), has good 
diagnostic efficiency (>.70), and robust psychometrics with a variety of trauma.43 
Patient Health Questionnaire (PHQ-9) 
The PHQ-9 Is a self-report questionnaire used to screen, diagnose, monitor, and 
measure the severity of depression.44 The tool rates the frequency of the symptoms 
which factors into the scoring severity index. The symptoms are scored from not at all 
(0) to nearly every day (3). The instrument has a sensitivity of 88% and a specificity of 
88% for major depression. The scores range from 5 (mild), 10 (moderate), 15 
(moderately severe), and 20 (severe) depression. 
Peer support and treatment modality 
The primary focus of study was the introduction of a supportive peer during three to 
four in vivo homework assignments per week for 3–4 weeks of the 12-week treatment. 
Peer support within PE treatment is supported by the social support evidence 
discussed previously and the actionable options recommended within the VHA.39 A 
variable carried over from the parent studies was the delivery modality of PE: home-
based telemedicine versus standard, in-person office-based sessions. 
Results 
Measures of PTSD were collected every two weeks per VA guidelines for PTSD clinics 
and revealed the time course of therapeutic effects, as illustrated in Figure 1. PCL-M 
scores at week 0 of the peer support program averaged about 65 for both groups 
(home-based telehealth x̅ = 65.5, SD = 11.0; in person x̅ = 65.3, SD = 9.4) and showed 
a typical pattern of early intensification, followed by gradual reduction at week 12 for 
both groups (home-based telehealth x̅ = 45.4; SD = 4.1; in person x̅ = 49.7, SD = 6.1). 
Depression measures were only taken at week 0 (home-based telehealth x̅ = 19.8, 
SD = 6.4; in person x̅ = 15.3, SD = 3.8) and week 12 (home-based telehealth x̅ = 9.4, 
SD = 0.2; in person x̅ = 9.1, SD = 0.2) and reflected a reduction higher in intensity in the 
teleheath group, as illustrated in Figure 2. 
 
Figure 1. PCL-M scores of PE dropouts who returned to therapy with assistance of a 
peer. PCL-M: post-traumatic stress disorder checklist—military version; PE: prolonged 
exposure. 
 Figure 2. PHQ-9 scores of PE dropouts who returned to therapy with assistance of a 
peer. PE: prolonged exposure; PHQ-9: Patient Health Questionnaire, 9th edition. 
Cognizant of low power, a preliminary comparison of treatment response in terms of 
treatment delivery modality (i.e., home-based telehealth versus in person), was 
conducted using repeated measures analysis of variances comparing week 0 and 
week 12 in terms both PCL-M and PHQ-9 outcomes. These analyses revealed a 
significant effect of time, but not of treatment modality or the interaction between the 
two, indicating that participants who had dropped out but returned to treatment, this 
time with the assistance of a peer, evidenced significant reductions in PCL-M scores 
by week 12, irrespective of group membership (see Table 2). Similarly, considering the 
PHQ-9 (see Table 3), there was a significant effect of time, in that both groups reported 
lower levels of depression by the end of peer-assisted PE. There was also a significant 
between-groups effect in that those receiving treatment via home-based telehealth 
reported higher week 0 PHQ-9 scores, but about the same week 12 PHQ-9 scores, 
thereby evincing an overall larger decline in scores. 
Table 2. Repeated measures descriptive and analysis of variance (ANOVA) results: PCL-
M scores week 0 versus week 12. 
 
PCL-M: post-traumatic stress disorder checklist—military version; SS: Sum 
Squares; MS: Mean Squares.AQ7 
Table 3. Repeated measures descriptive and ANOVA results: PHQ-9 scores week 0 
versus week 12. 
 
Note. ANOVA: analysis of variance; PHQ-9: Patient Health Questionnaire, 9th 
edition; SS: Sum Squares; MS:Mean Squares. 
Discussion 
This study demonstrated potential utility of including peers directly during the in vivo 
exposure therapy homework component of PE in that just over half of those 
approached indicated a willingness to return to treatment, and about a third actually 
did so. Specifically, dropout was reversed in 29 of 82 participants upon the offer of 
participation in the peer support program, and following treatment, 21 of 29 (72%) 
evinced clinically significant (greater than 15 points) reductions on the PCL-M, with the 
same proportion evincing PHQ-9 scores below the cutoff for moderate depression (i.e., 
10). These findings are impressive given that all participants had already dropped out 
of treatment, and would have ostensibly endured PTSD symptoms and associated 
diminished quality of life for years or decades into the future, were this program not 
available. Although dropout was not entirely reversed, reengaging 35.4% of dropouts, 
and subsequently achieving clinically significant improvement in these patients, offers 
a potentially important means by which to reduce address the primary shortcoming 
associated with evidence-based therapies for PTSD, including PE. Given decades of 
evidence in support of PE for PTSD, guidelines from National Center on PTSD, the 
Institute of Medicine, and the DoD and VA supporting PE, and the significant 
investment by the VA and DoD in providing this evidence-based therapy to Veterans, 
findings that dropout can be effectively reversed are worthy of further study. 
In the present feasibility study, participants who dropped out of a clinical trial evaluating 
PE delivered in person versus home-based telehealth were simply offered the 
opportunity to try the same treatment again, this time with the social and verbal 
support, during a limited number of in vivo exposure homework episodes, by a peer 
who had been through the process. Peer training was brief, focused on the limits of 
their responsibility and safe conduct, and confined their role to that of supportive 
“workout buddy” during exposures, offering encouragement to “stick with the mission 
a bit longer.” This phrasing was actually used by peers and Veterans, who indicated 
that they approached exposures using the same mission-focused teamwork that they 
had been trained to use as service members. Leveraging this team-based, mission-
focused effort appeared quite useful insofar as patients and peers described the 
process as building on their prior training. 
Although reversing dropout is notable, the central clinical question remains one of 
symptom reduction. Indeed, psychological outcomes were improved. Participants in 
PE delivered via home-based telehealth or through traditional in person settings 
showed an average PCL-M reduction of 10–20 points, which is considered clinically 
significant. A similar reduction was observed for depression scores, with a slight 
advantage for patients in the telehealth condition due to their relatively higher level of 
symptomatology at baseline. An interesting observation is that both groups evinced a 
slight worsening of symptoms at week 4, perhaps coinciding with the time point at 
which participants shifted back to completed in vivo exposure homework 
independently for the remainder of the 12-week treatment, without the aid of the peer. 
This might be an indicator that the peer program was probably effective not because it 
made exposure homework easier, but because it made it more likely for exposure 
homework to be completed over time. 
The results of this study are promising, particularly given the easily disseminated, brief 
training program for peers in the context of VA efforts to roll out peer programs across 
its system. Findings provide preliminary support indicating that peer-based social 
support is an effective, readily available tool to address difficulties related to dropout 
from exposure-based therapy for PTSD. This study builds on a large body of work 
indicating the utility of peer-based support across seemingly disparate health and 
mental health issues, including promoting academic engagement in students with 
autism,45 diabetes management,46 and HIV47 to name a few. Moreover, results might 
have been even more impressive if the peer program were offered to those 
contemplating dropout, rather than to those who had already left treatment. 
Limitations of the present study include the lack of a no-peer comparison group and 
subsequent random assignment to condition, the small sample size, and use of a 
potentially atypical sample of Veterans who had, at least originally, consented to be 
part of an experimental clinical trial and who may differ from typical clinical patients. 
Moreover, the timing of this intervention (i.e., post dropout) may not be optimum insofar 
as it seems likely that offering peer support during exposure homework to those 
contemplating dropout, rather than waiting for them to drop out, may have prevented 
a greater proportion of early treatment termination relative to treatment reengagement. 
Future studies should build on this preliminary study using a sufficiently powered 
between-groups design with an appropriate comparator (e.g., peer support offered 
outside of treatment components) so as to support causal inferences with respect to 
the utility of this type of peer support program. Moreover, dropouts from a standard VA 
PTSD clinic, rather than dropouts from a formal treatment outcome study, should be 
used as participants to enhance generalizability. Finally, an experimental manipulation 
of timing (i.e., offering the program to those contemplating dropout, rather than waiting 
for dropout to occur) may be warranted insofar as it may be more effective to prevent, 
than reverse dropout. 
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